143 related articles for article (PubMed ID: 17032415)
1. Systemic mediators induce fibrogenic effects in normal liver after partial bile duct ligation.
Osawa Y; Seki E; Adachi M; Taura K; Kodama Y; Siegmund SV; Schwabe RF; Brenner DA
Liver Int; 2006 Nov; 26(9):1138-47. PubMed ID: 17032415
[TBL] [Abstract][Full Text] [Related]
2. Adenoviral expression of a transforming growth factor-beta1 antisense mRNA is effective in preventing liver fibrosis in bile-duct ligated rats.
Arias M; Sauer-Lehnen S; Treptau J; Janoschek N; Theuerkauf I; Buettner R; Gressner AM; Weiskirchen R
BMC Gastroenterol; 2003 Oct; 3():29. PubMed ID: 14565855
[TBL] [Abstract][Full Text] [Related]
3. A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populations.
Magness ST; Bataller R; Yang L; Brenner DA
Hepatology; 2004 Nov; 40(5):1151-9. PubMed ID: 15389867
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis.
Kisseleva T; Uchinami H; Feirt N; Quintana-Bustamante O; Segovia JC; Schwabe RF; Brenner DA
J Hepatol; 2006 Sep; 45(3):429-38. PubMed ID: 16846660
[TBL] [Abstract][Full Text] [Related]
5. The caspase inhibitor IDN-6556 attenuates hepatic injury and fibrosis in the bile duct ligated mouse.
Canbay A; Feldstein A; Baskin-Bey E; Bronk SF; Gores GJ
J Pharmacol Exp Ther; 2004 Mar; 308(3):1191-6. PubMed ID: 14617689
[TBL] [Abstract][Full Text] [Related]
6. IFN-gamma abrogates profibrogenic TGF-beta signaling in liver by targeting expression of inhibitory and receptor Smads.
Weng H; Mertens PR; Gressner AM; Dooley S
J Hepatol; 2007 Feb; 46(2):295-303. PubMed ID: 17125875
[TBL] [Abstract][Full Text] [Related]
7. Bile acid-mediated thrombospondin-1 induction in hepatocytes leads to transforming growth factor-beta-dependent hepatic stellate cell activation.
Myung SJ; Yoon JH; Gwak GY; Kim W; Yang JI; Lee SH; Jang JJ; Lee HS
Biochem Biophys Res Commun; 2007 Feb; 353(4):1091-6. PubMed ID: 17204245
[TBL] [Abstract][Full Text] [Related]
8. Effects of RNA interference targeting transforming growth factor-beta 1 on immune hepatic fibrosis induced by Concanavalin A in mice.
Xu W; Wang LW; Shi JZ; Gong ZJ
Hepatobiliary Pancreat Dis Int; 2009 Jun; 8(3):300-8. PubMed ID: 19502172
[TBL] [Abstract][Full Text] [Related]
9. Contribution of hepatic parenchymal and nonparenchymal cells to hepatic fibrogenesis in biliary atresia.
Ramm GA; Nair VG; Bridle KR; Shepherd RW; Crawford DH
Am J Pathol; 1998 Aug; 153(2):527-35. PubMed ID: 9708812
[TBL] [Abstract][Full Text] [Related]
10. Gene expression profiles during hepatic stellate cell activation in culture and in vivo.
De Minicis S; Seki E; Uchinami H; Kluwe J; Zhang Y; Brenner DA; Schwabe RF
Gastroenterology; 2007 May; 132(5):1937-46. PubMed ID: 17484886
[TBL] [Abstract][Full Text] [Related]
11. Polyphenols from Camellia sinenesis attenuate experimental cholestasis-induced liver fibrosis in rats.
Zhong Z; Froh M; Lehnert M; Schoonhoven R; Yang L; Lind H; Lemasters JJ; Thurman RG
Am J Physiol Gastrointest Liver Physiol; 2003 Nov; 285(5):G1004-13. PubMed ID: 12791596
[TBL] [Abstract][Full Text] [Related]
12. Hepatic stellate cell-targeted delivery of M6P-HSA-glycyrrhetinic acid attenuates hepatic fibrogenesis in a bile duct ligation rat model.
Luk JM; Zhang QS; Lee NP; Wo JY; Leung PP; Liu LX; Hu MY; Cheung KF; Hui CK; Lau GK; Fan ST
Liver Int; 2007 May; 27(4):548-57. PubMed ID: 17403195
[TBL] [Abstract][Full Text] [Related]
13. Systemic infusion of angiotensin II exacerbates liver fibrosis in bile duct-ligated rats.
Bataller R; Gäbele E; Parsons CJ; Morris T; Yang L; Schoonhoven R; Brenner DA; Rippe RA
Hepatology; 2005 May; 41(5):1046-55. PubMed ID: 15841463
[TBL] [Abstract][Full Text] [Related]
14. Enhanced expression of transforming growth factor-beta 1 in inflammatory cells, alpha-smooth muscle actin in stellate cells, and collagen accumulation in experimental granulomatous hepatitis caused by Toxocara canis in mice.
Wu MS; Liao CW; Du WY; Kao TC; Su KE; Lin YH; Chang CC; Fan CK
Acta Trop; 2008 Mar; 105(3):260-8. PubMed ID: 18178169
[TBL] [Abstract][Full Text] [Related]
15. Selective activation of Toll-like receptor 7 in activated hepatic stellate cells may modulate their profibrogenic phenotype.
Chou MH; Huang YH; Lin TM; Du YY; Tsai PC; Hsieh CS; Chuang JH
Biochem J; 2012 Oct; 447(1):25-34. PubMed ID: 22765640
[TBL] [Abstract][Full Text] [Related]
16. Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells.
Hellerbrand ; Wang SC; Tsukamoto H; Brenner DA; Rippe RA
Hepatology; 1996 Sep; 24(3):670-6. PubMed ID: 8781341
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of plasminogen activator inhibitor-1 expression by siRNA in rat hepatic stellate cells.
Hu PF; Zhu YW; Zhong W; Chen YX; Lin Y; Zhang X; Yin C; Yue HY; Xie WF
J Gastroenterol Hepatol; 2008 Dec; 23(12):1917-25. PubMed ID: 18761555
[TBL] [Abstract][Full Text] [Related]
18. A high-cholesterol diet exacerbates liver fibrosis in mice via accumulation of free cholesterol in hepatic stellate cells.
Teratani T; Tomita K; Suzuki T; Oshikawa T; Yokoyama H; Shimamura K; Tominaga S; Hiroi S; Irie R; Okada Y; Kurihara C; Ebinuma H; Saito H; Hokari R; Sugiyama K; Kanai T; Miura S; Hibi T
Gastroenterology; 2012 Jan; 142(1):152-164.e10. PubMed ID: 21995947
[TBL] [Abstract][Full Text] [Related]
19. c-Met confers protection against chronic liver tissue damage and fibrosis progression after bile duct ligation in mice.
Giebeler A; Boekschoten MV; Klein C; Borowiak M; Birchmeier C; Gassler N; Wasmuth HE; Müller M; Trautwein C; Streetz KL
Gastroenterology; 2009 Jul; 137(1):297-308, 308.e1-4. PubMed ID: 19208365
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new bioactive lipid-based drug carrier on cultured hepatic stellate cells and liver fibrosis in bile duct-ligated rats.
Adrian JE; Poelstra K; Scherphof GL; Meijer DK; van Loenen-Weemaes AM; Reker-Smit C; Morselt HW; Zwiers P; Kamps JA
J Pharmacol Exp Ther; 2007 May; 321(2):536-43. PubMed ID: 17314198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
